Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 transmission in the U.S. before vs. after relaxation of state social distancing measures

View ORCID ProfileAlexander C. Tsai, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Mark J. Siedner
doi: https://doi.org/10.1101/2020.07.15.20154534
Alexander C. Tsai
1Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States
2Harvard Medical School, Boston, Massachusetts, United States
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander C. Tsai
Guy Harling
3University College London, London, United Kingdom
4Africa Health Research Institute, KwaZulu-Natal, South Africa
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zahra Reynolds
5Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca F. Gilbert
5Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Siedner
1Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts, United States
2Harvard Medical School, Boston, Massachusetts, United States
4Africa Health Research Institute, KwaZulu-Natal, South Africa
5Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: msiedner@partners.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Weeks after issuing social distancing orders, all U.S. states and the District of Columbia at least partially relaxed these measures. Critical unanswered questions remain about the timing of relaxation, and if and how unregulated social distancing measures can be sustained while effectively maintaining epidemic control.

Methods We identified all statewide social distancing measures that were implemented and/or relaxed in the U.S. between March 10-July 15, 2020, triangulating data from state government and third-party sources. Using segmented linear regression, we evaluated the extent to which social distancing measure relaxation affected epidemic control, as indicated by the time-varying, state-specific effective reproduction number (Rt).

Results In the eight weeks prior to relaxation, mean Rt declined by 0.012 units per day (95% CI, -0.013 to -0.012), and 46/51 jurisdictions achieved Rt < 1.0 by the date of relaxation. After relaxation of social distancing, Rt reversed course and began increasing by 0.007 units per day (95% CI, 0.006-0.007), reaching a mean Rt of 1.16 eight weeks later, with only 9/51 jurisdictions maintaining Rt <1.0. Indicators often used to motivate relaxation at the time of relaxation (e.g. test positivity rate <5%) predicted greater post-relaxation epidemic growth.

Conclusions We detected an immediate and significant reversal in epidemic growth gains after relaxation of social distancing measures across the U.S. These results illustrate the potential pitfalls of premature relaxation of social distancing measures in the U.S.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Sir Henry Dale Fellowship, Wellcome Trust (UK); Sullivan Family Foundation

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This ecological analysis was based on publicly available data and was exempt from ethical review.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Article Summary: Using segmented linear regression, we evaluated how state government relaxation of social distancing measures affected the time-varying effective reproduction number. We detected an immediate and significant reversal in epidemic growth gains after relaxation of social distancing measures across the U.S.

  • Conflict of interest: All authors declare no competing interests. There was no independent funding source for this work.|

  • Augmented with data collected through July 15, 2020. Seven sensitivity analyses added.

Data Availability

The data on social distancing policies are contained within the Supplementary Appendix Table. The data on COVID-19 cases and deaths are publicly available from https://github.com/nytimes/covid-19-data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 07, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 transmission in the U.S. before vs. after relaxation of state social distancing measures
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 transmission in the U.S. before vs. after relaxation of state social distancing measures
Alexander C. Tsai, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Mark J. Siedner
medRxiv 2020.07.15.20154534; doi: https://doi.org/10.1101/2020.07.15.20154534
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 transmission in the U.S. before vs. after relaxation of state social distancing measures
Alexander C. Tsai, Guy Harling, Zahra Reynolds, Rebecca F. Gilbert, Mark J. Siedner
medRxiv 2020.07.15.20154534; doi: https://doi.org/10.1101/2020.07.15.20154534

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)